-
13122-5An aminopyrimidine derivative that inhibits GSK3&alpha and GSK3&beta (IC50s = 10 and 6.7 nM, respectively) activates glycogen synthesis in CHO-IR cells (EC50 = 0.
-
16379-10A form of chitobiose containing eight acetate groups.
-
16379-100A form of chitobiose containing eight acetate groups.
-
16379-25A form of chitobiose containing eight acetate groups.
-
16379-50A form of chitobiose containing eight acetate groups.
-
A9912-5 mg
Thomas Scientific
CHK1 inhibitor. It increases sensitivity to DNA-damaging compounds and inhibits proliferation of breast cancer and ovarian cancer cells. (C08-0488-989)
Price: $279.67List Price: $310.75AZD-7762 is an inhibitor of checkpoint kinase 1 (Chk1) that increases sensitivity to DNA-damaging compounds. AZD-7762 exhibits anticancer chemotherapeutic activity and is currently in clinical trials as a potential treatment for a variety of cancers. -
A9912-10 mg
Thomas Scientific
CHK1 inhibitor. It increases sensitivity to DNA-damaging compounds and inhibits proliferation of breast cancer and ovarian cancer cells. (C08-0489-258)
Price: $439.54List Price: $488.38AZD-7762 is an inhibitor of checkpoint kinase 1 (Chk1) that increases sensitivity to DNA-damaging compounds. AZD-7762 exhibits anticancer chemotherapeutic activity and is currently in clinical trials as a potential treatment for a variety of cancers. -
17552-1A selective, ATP-competitive inhibitor of the DNA damage control kinase, Chk2 (IC<sub>50</sub> = 15 nM) prevents apoptosis in human T-cells exposed to ionizing radiation (EC<sub>50</sub> = 3-7.6 µM).
-
17552-10A selective, ATP-competitive inhibitor of the DNA damage control kinase, Chk2 (IC<sub>50</sub> = 15 nM) prevents apoptosis in human T-cells exposed to ionizing radiation (EC<sub>50</sub> = 3-7.6 µM).
-
17552-5A selective, ATP-competitive inhibitor of the DNA damage control kinase, Chk2 (IC<sub>50</sub> = 15 nM) prevents apoptosis in human T-cells exposed to ionizing radiation (EC<sub>50</sub> = 3-7.6 µM).
-
19239-1A histamine H1 receptor antagonist (Ki = 9 nM) that is effective against HCV (EC<sub>50</sub> = 44 nM), preventing viral entry into host cells.
-
19239-100A histamine H1 receptor antagonist (Ki = 9 nM) that is effective against HCV (EC<sub>50</sub> = 44 nM), preventing viral entry into host cells.